Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Elbit Imaging Ord (EMITF) NASDAQ

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]] [[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
3-Month Performance
View Chart

Fundamentals

See More
  • Market Capitalization, $K 30,970
  • Shares Outstanding, K 9,190
  • Annual Sales, $ 89,180 K
  • Annual Income, $ -47,710 K
  • 36-Month Beta -0.48
  • Price/Sales 0.55
  • Price/Book 0.50

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.28 +1.22%
on 01/19/17
3.74 -11.23%
on 01/06/17
-0.31 (-8.54%)
since 12/20/16
3-Month
3.28 +1.22%
on 01/19/17
3.94 -15.74%
on 10/26/16
-0.53 (-13.77%)
since 10/20/16
52-Week
1.89 +75.66%
on 02/22/16
4.04 -17.82%
on 09/08/16
+1.31 (+65.17%)
since 01/20/16

Most Recent Stories

More News
Elbit Imaging Ltd. Announces That INSIGHTEC's Exablate Neuro System Has Been Approved by MHLW (Japan) for the Treatment of Essential Tremor and That INSIGHTEC's Exablate System Has Been Approved by EU (CE) for the Treatment of Prostate Cancer

Elbit Imaging Ltd. (TASE:EMITF) (NASDAQ:EMITF) ("Elbit" or the "Company") announced today that it was informed by INSIGHTEC Ltd. ("INSIGHTEC"), that the Exablate system ("Exablate") received CE Mark for...

Elbit Imaging Ltd. Announces Notes Buyback

Elbit Imaging Ltd. ("EI" or the "Company") (TASE:EMITF) (NASDAQ:EMITF) announced today, further to the Company's announcements dated June 1 and August 18, 2016 regarding the Board of Directors resolution...

Elbit Imaging Ltd. Announces That Gamida Cell's Phase 3 Study of NiCord for Blood Cancers is Now Enrolling

Elbit Imaging Ltd. (TASE:EMITF) (NASDAQ:EMITF) ("Elbit" or the "Company") announced today that it was informed by Gamida Cell Ltd. ("Gamida Cell"), an indirect associate of the Company, that Gamida Cell...

Elbit Imaging Announces an Acquisition of Loan Secured Against Asset in Romania by Its Subsidiary, Plaza Centers

Elbit Imaging Ltd. ("EI" or the "Company") (TASE:EMITF), (NASDAQ:EMITF) announced today, that a fully owned subsidiary of Plaza Centers N.V. ("Plaza") (LSE:PLAZ), an indirect subsidiary (45%) of the Company,...

Elbit Imaging Announces Update Regarding the Ruling of the International Court of Arbitration in Relation to Its Subsidiary, Plaza Centers

Elbit Imaging Ltd. ("EI" or the "Company") (TASE:EMITF) (NASDAQ:EMITF) announced today, further to the announcement dated July 7, 2016, regarding the ruling of the International Court of Arbitration in...

Elbit Imaging Announces Update Regarding the Termination of the Agreement With the Israel Land Authority Regarding Land Plot Near Tiberius Israel

Elbit Imaging Ltd. ("EI" or the "Company") (TASE:EMITF) (NASDAQ:EMITF) announced today, in further to the announcement dated July 5, 2016, regarding the termination of an agreement with the Israel Land...

Elbit Imaging Ltd. Announces Refusal to the Debt Conversion Proposal From Its Subsidiary Elbit Medical Technologies Ltd and Extension to the Debt of Elbit Medical Technologies Ltd Maturity Date

Elbit Imaging Ltd. (the "Company") (TASE:EMITF) (NASDAQ:EMITF) announced today, in furtherance to its announcement dated March 17, 2016, regarding the proposal from its subsidiary, Elbit Medical Technologies...

Elbit Imaging Ltd. Announces Closing of the Second Tranche of the Refinancing of the Radisson Blu Hotel in Bucharest

Elbit Imaging Ltd. ("Company") (TASE:EMITF) (NASDAQ:EMITF) announced today, further to its announcements dated March 10, 2016 and March 24, 2016, that its approximately 98% holding subsidiary, Bucuresti...

Elbit Imaging Announces Amendment to the 2014 Restructuring Plan of Its Subsidiary, Plaza Centers

Elbit Imaging Ltd. ("EI" or the "Company") (TASE:EMITF) (NASDAQ:EMITF) announced today, in further to its announcement dated on July 21, 2014, regarding the restructuring plan approval of Plaza Centers...

Elbit Imaging Announces Update Regarding a Possible Forward Sale Transaction of Belgrade Plaza (Visnjicka) by Its Subsidiary, Plaza Centers

Elbit Imaging Ltd. ("EI" or the "Company") (TASE:EMITF) (NASDAQ:EMITF) announced today, in further to its announcement dated on October 26, 2016, that Plaza Centers N.V. ("Plaza") (LSE:PLAZ), an indirect...

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More

Business Summary

Elbit Imaging Ltd. is involved in commercial centers, hotels, medical industries and plots businesses primarily in Western Europe, Central and Eastern Europe and internationally. The company's operating fields of business consists of Commercial centers - initiation, construction, and sale of commercial...

See More

Support & Resistance

2nd Resistance Point 3.32
1st Resistance Point 3.32
Last Price 3.32
1st Support Level 3.32
2nd Support Level 3.32

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.